341 related articles for article (PubMed ID: 14760896)
21. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
De Felipe B; Blanco A; Soriano-Sarabia N; Muñoz-Fernández MA; Genebat M; Vallejo A; Leal M
Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
[TBL] [Abstract][Full Text] [Related]
22. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
Saint-Marc T; Partisani M; Poizot-Martin I; Bruno F; Rouviere O; Lang JM; Gastaut JA; Touraine JL
AIDS; 1999 Sep; 13(13):1659-67. PubMed ID: 10509567
[TBL] [Abstract][Full Text] [Related]
23. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
24. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
Maia BS; Engelson ES; Wang J; Kotler DP
Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
[TBL] [Abstract][Full Text] [Related]
25. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
[TBL] [Abstract][Full Text] [Related]
26. Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.
Jones SP; Qazi N; Morelese J; Lebrecht D; Sutinen J; Yki-Jărvinen H; Back DJ; Pirmohamed M; Gazzard BG; Walker UA; Moyle GJ
J Acquir Immune Defic Syndr; 2005 Dec; 40(5):565-72. PubMed ID: 16284533
[TBL] [Abstract][Full Text] [Related]
27. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.
Mallon PW; Unemori P; Sedwell R; Morey A; Rafferty M; Williams K; Chisholm D; Samaras K; Emery S; Kelleher A; Cooper DA; Carr A;
J Infect Dis; 2005 May; 191(10):1686-96. PubMed ID: 15838796
[TBL] [Abstract][Full Text] [Related]
28. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
[TBL] [Abstract][Full Text] [Related]
29. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.
Kakuda TN
Clin Ther; 2000 Jun; 22(6):685-708. PubMed ID: 10929917
[TBL] [Abstract][Full Text] [Related]
31. Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues.
Caron M; Auclairt M; Vissian A; Vigouroux C; Capeau J
Antivir Ther; 2008; 13(1):27-38. PubMed ID: 18389896
[TBL] [Abstract][Full Text] [Related]
32. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.
Nolan D; Mallal S
J HIV Ther; 2004 May; 9(2):34-40. PubMed ID: 15238874
[TBL] [Abstract][Full Text] [Related]
33. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.
Lo JC; Kazemi MR; Hsue PY; Martin JN; Deeks SG; Schambelan M; Mulligan K
Clin Infect Dis; 2005 Nov; 41(9):1335-40. PubMed ID: 16206112
[TBL] [Abstract][Full Text] [Related]
34. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions.
Walker UA; Auclair M; Lebrecht D; Kornprobst M; Capeau J; Caron M
Antivir Ther; 2006; 11(1):25-34. PubMed ID: 16518957
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P
J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells.
Papp E; Gadawski I; Côté HC
J Antimicrob Chemother; 2008 May; 61(5):1048-52. PubMed ID: 18310046
[TBL] [Abstract][Full Text] [Related]
38. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
[TBL] [Abstract][Full Text] [Related]
39. Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Justice AC; Stein DS; Fusco GP; Sherrill BH; Fusco JS; Danehower SC; Becker SL; Hansen NI; Graham NM;
J Clin Epidemiol; 2004 Jan; 57(1):89-97. PubMed ID: 15019015
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial toxicity of indinavir, stavudine and zidovudine involves multiple cellular targets in white and brown adipocytes.
Viengchareun S; Caron M; Auclair M; Kim MJ; Frachon P; Capeau J; Lombès M; Lombès A
Antivir Ther; 2007; 12(6):919-29. PubMed ID: 17926646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
